CD8A and neoplasm: To define the immune mechanism and evaluate the immunologic efficacy of Lm-LLO-E7/anti-PD-1 Ab combination we next assessed the levels of antigen-specific IFNγ-producing cells in spleens from treated tumor-bearing mice and tumor-infiltrated CD8 T cells.